Skip to content
    Back to Database
    Botanical ExtractsNatural

    Mucuna Pruriens

    Also known as: Velvet bean, Mucuna pruriens, 99% L-DOPA

    Standardised Mucuna pruriens seed extract delivering L-DOPA (typically 15–99%); L-DOPA crosses the BBB and is decarboxylated to dopamine.

    Last reviewed: 2026-06-23 · 1 indexed study

    Evidence Score
    56/100
    Dopamine supportMoodLibidoCognitive drive
    Data Completeness3/4 · 75%
    Evidence ScoreDosageSafetyLinked Studies

    Set your location for accurate regulatory status

    Saved on this device — no sign-in needed.

    Sign in to add to stack

    Overview

    Mucuna pruriens (velvet bean) is a natural source of L-DOPA, the direct precursor to dopamine; high-percentage L-DOPA extracts have pharmacological-level activity.

    Mechanism & Function

    Mechanism of Action

    Raises central dopamine, supporting drive, mood, libido, and motor function; pharmacologically active at high-L-DOPA doses.

    Physiological Role

    Used for mood and drive in nootropic stacks; 99% L-DOPA extracts approach prescription-strength dopamine effects and warrant caution.

    Primary Pathways

    L-DOPA→dopamine conversionAromatic L-amino acid decarboxylaseReduced prolactin

    Performance / Health Relevance

    Clinical evidence in Parkinson's disease (as L-DOPA source); healthy-user data weaker.

    Evidence Review

    Overall56/100
    Human Clinical62/100
    Meta-Analysis55/100
    Mechanistic85/100
    Real-World55/100
    Safety70/100

    Practical Use & Dosage

    Minimum Effective Dose
    50 mg L-DOPA
    Optimal Range
    100–200 mg L-DOPA equivalent
    Upper / Caution Level
    ~500 mg L-DOPA (Parkinson's doses)
    Timing
    With food, morning
    Best Format
    Capsule (varies by L-DOPA %)
    Bioavailability
    High for L-DOPA component.
    Absorption Considerations
    L-DOPA actively transported; large neutral AA competition reduces absorption.

    Safety & Interactions

    Side Effects

    • •Nausea
    • •Insomnia
    • •Hypotension
    • •Compulsive behaviour (high dose)
    • •Dyskinesia (very high dose)

    Contraindications

    • Pregnancy
    • Psychotic disorders
    • Melanoma
    • MAOI use

    Drug Interactions

    • •MAOIs
    • •Antipsychotics
    • •Levodopa (additive)
    • •Antihypertensives

    Who Should Avoid

    • •Bipolar
    • •Schizophrenia
    • •Pregnancy

    Monitoring

    BP, mood; cycle to avoid tolerance.

    Frequently Asked Questions

    Auto-generated from indexed evidence — dosage, safety, interactions, and more.

    When is Mucuna Pruriens typically used or indicated?

    Mucuna Pruriens is most commonly used for: Dopamine support, Mood, Libido, Cognitive drive. Used for mood and drive in nootropic stacks; 99% L-DOPA extracts approach prescription-strength dopamine effects and warrant caution.

    How does Mucuna Pruriens work?

    Raises central dopamine, supporting drive, mood, libido, and motor function; pharmacologically active at high-L-DOPA doses.

    What is the recommended dose of Mucuna Pruriens?

    The optimal range is 100–200 mg L-DOPA equivalent. with a minimum effective dose of 50 mg L-DOPA. Best taken: With food, morning. Upper / caution level: ~500 mg L-DOPA (Parkinson's doses).

    What are the side effects of Mucuna Pruriens?

    Reported side effects include: Nausea; Insomnia; Hypotension; Compulsive behaviour (high dose); and Dyskinesia (very high dose). Monitoring: BP, mood; cycle to avoid tolerance.

    Does Mucuna Pruriens interact with medications?

    Known or theoretical interactions: MAOIs; Antipsychotics; Levodopa (additive); and Antihypertensives. Always check with a clinician before combining with prescription medication.

    Who should avoid Mucuna Pruriens?

    Mucuna Pruriens is generally not recommended for: Bipolar; Schizophrenia; Pregnancy; Pregnancy; Psychotic disorders; Melanoma; and MAOI use.

    How strong is the evidence for Mucuna Pruriens?

    Evidence level: Moderate (overall score 56/100), based on 1 indexed study on SuppIndex.

    Research & References (1)

    Mucuna pruriens for Parkinson's disease and dopaminergic effects

    Systematic Review2014Moderate
    PubMed

    Mucuna pruriens provides L-DOPA with possibly improved tolerability vs synthetic levodopa; replication needed.

    Related Ingredients

    Other top-rated ingredients in Botanical Extracts.

    Curcumin

    85/100

    Polyphenolic compound that modulates NF-κB, COX-2, and multiple inflammatory cascades with demonstrated efficacy comparable to NSAIDs in some osteoarthritis trials, when bioavailability-enhanced formulations are used.

    Pycnogenol

    78/100

    Standardised pine bark extract delivering procyanidins, catechins, and phenolic acids; raises eNOS-derived NO, scavenges ROS, and supports collagen integrity.

    Rhodiola Rosea

    76/100

    Adaptogenic botanical containing rosavins and salidroside that modulate cortisol response, enhance stress resilience, and improve cognitive and physical performance under fatigue conditions.

    Research Overview

    Moderate Evidence
    1Total Studies
    0Human Trials
    0Meta-Analyses
    2014Latest Study
    0Animal / In Vitro
    0Athlete Studies
    Primary data sourceClinical Patients
    Pooled evidence (meta-analysis / systematic review)Yes

    Cite this ingredient

    One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.

    Stable URL

    https://thesuppindex.com/ingredients/mucuna-pruriens

    SuppIndex. (2026). Mucuna Pruriens: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/mucuna-pruriens

    Based on 1 indexed studies · Evidence level: Moderate.

    Goal Ratings

    Focus
    Stress
    Hormonal Support
    Cognition

    Stack Compatibility

    Cycle 5 days on / 2 off; avoid with MAOIs or antipsychotics.

    L-TyrosineB6Vitamin C